108 related articles for article (PubMed ID: 25469978)
21. The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.
Perez Montiel D; Arispe Angulo K; Cantú-de León D; Bornstein Quevedo L; Chanona Vilchis J; Herrera Montalvo L
Ann Diagn Pathol; 2015 Aug; 19(4):249-52. PubMed ID: 26059401
[TBL] [Abstract][Full Text] [Related]
22. SATB2 is a supplementary immunohistochemical marker to CDX2 in the diagnosis of colorectal carcinoma metastasis in an unknown primary.
Dabir PD; Svanholm H; Christiansen JJ
APMIS; 2018 Jun; 126(6):494-500. PubMed ID: 29924451
[TBL] [Abstract][Full Text] [Related]
23. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
[TBL] [Abstract][Full Text] [Related]
24. Metformin reduces SATB2-mediated osteosarcoma stem cell-like phenotype and tumor growth via inhibition of N-cadherin/NF-kB signaling.
Xu HY; Fang W; Huang ZW; Lu JC; Wang YQ; Tang QL; Song GH; Kang Y; Zhu XJ; Zou CY; Yang HL; Shen JN; Wang J
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4516-4528. PubMed ID: 29131265
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.
Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C
Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987
[TBL] [Abstract][Full Text] [Related]
26. SATB2 as an Immunohistochemical Marker for Colorectal Adenocarcinoma: A Concise Review of Benefits and Pitfalls.
Berg KB; Schaeffer DF
Arch Pathol Lab Med; 2017 Oct; 141(10):1428-1433. PubMed ID: 28968158
[TBL] [Abstract][Full Text] [Related]
27. Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker.
Yu W; Ma Y; Shankar S; Srivastava RK
Oncotarget; 2016 Sep; 7(36):57783-57797. PubMed ID: 27472393
[TBL] [Abstract][Full Text] [Related]
28. [Significance of SATB2 in the pathologic diagnosis of osteosarcoma].
Li M; Cai YP; Lu KY; Chen Y; Zhu X; Yin Y; Tang J
Zhonghua Bing Li Xue Za Zhi; 2016 Sep; 45(9):631-5. PubMed ID: 27646893
[TBL] [Abstract][Full Text] [Related]
29. Lentiviral-mediated expression of SATB2 promotes osteogenic differentiation of bone marrow stromal cells in vitro and in vivo.
Gong Y; Qian Y; Yang F; Wang H; Yu Y
Eur J Oral Sci; 2014 Jun; 122(3):190-7. PubMed ID: 24666017
[TBL] [Abstract][Full Text] [Related]
30. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
Li Y; Liu YH; Hu YY; Chen L; Li JM
World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
[TBL] [Abstract][Full Text] [Related]
31. Expression of Sp7 in Satb2-induced osteogenic differentiation of mouse bone marrow stromal cells is regulated by microRNA-27a.
Gong Y; Lu J; Yu X; Yu Y
Mol Cell Biochem; 2016 Jun; 417(1-2):7-16. PubMed ID: 27142530
[TBL] [Abstract][Full Text] [Related]
32. Regulative Effect of Mir-205 on Osteogenic Differentiation of Bone Mesenchymal Stem Cells (BMSCs): Possible Role of SATB2/Runx2 and ERK/MAPK Pathway.
Hu N; Feng C; Jiang Y; Miao Q; Liu H
Int J Mol Sci; 2015 May; 16(5):10491-506. PubMed ID: 25961955
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of SATB2 expression in patients with esophageal squamous cell carcinoma.
Geng GJ; Li N; Mi YJ; Yu XY; Luo XY; Gao J; Luo QC; Xie JD; Fa XE; Jiang J
Int J Clin Exp Pathol; 2015; 8(1):423-31. PubMed ID: 25755730
[TBL] [Abstract][Full Text] [Related]
34. Sclerosing epithelioid fibrosarcoma of the thigh: report of two cases with synchronous bone metastases.
Righi A; Gambarotti M; Manfrini M; Benini S; Gamberi G; Cocchi S; Casadei R; Picci P; Vanel D; Dei Tos AP
Virchows Arch; 2015 Sep; 467(3):339-44. PubMed ID: 26209924
[TBL] [Abstract][Full Text] [Related]
35. Special AT-rich sequence-binding protein 2 and its related genes play key roles in the differentiation of MC3T3-E1 osteoblast like cells.
Kim IS; Jeong SJ; Kim SH; Jung JH; Park YG; Kim SH
Biochem Biophys Res Commun; 2012 Jan; 417(2):697-703. PubMed ID: 22166200
[TBL] [Abstract][Full Text] [Related]
36. Transplantation of osteoporotic bone marrow stromal cells rejuvenated by the overexpression of SATB2 prevents alveolar bone loss in ovariectomized rats.
Xu R; Fu Z; Liu X; Xiao T; Zhang P; Du Y; Yuan H; Cheng J; Jiang H
Exp Gerontol; 2016 Nov; 84():71-79. PubMed ID: 27599698
[TBL] [Abstract][Full Text] [Related]
37. Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue-specific manner and demonstrates cell-type-dependent expression in the developing mouse CNS.
Britanova O; Akopov S; Lukyanov S; Gruss P; Tarabykin V
Eur J Neurosci; 2005 Feb; 21(3):658-68. PubMed ID: 15733084
[TBL] [Abstract][Full Text] [Related]
38. SATB2 is not a reliable diagnostic marker for distinguishing between oral osteosarcoma and fibro-osseous lesions of the jaws.
Grad-Akrish S; Rachmiel A; Ben-Izhak O
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 May; 131(5):572-581. PubMed ID: 33309262
[TBL] [Abstract][Full Text] [Related]
39. Effects of a miR-31, Runx2, and Satb2 regulatory loop on the osteogenic differentiation of bone mesenchymal stem cells.
Deng Y; Wu S; Zhou H; Bi X; Wang Y; Hu Y; Gu P; Fan X
Stem Cells Dev; 2013 Aug; 22(16):2278-86. PubMed ID: 23517179
[TBL] [Abstract][Full Text] [Related]
40. Satb2
Ambrozkiewicz MC; Bessa P; Salazar-Lázaro A; Salina V; Tarabykin V
J Neurosci Methods; 2017 Nov; 291():113-121. PubMed ID: 28782628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
